• Explore /
  • Poster
  • / A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.

Abstract Poster

Authors

Saurav Haldar

Saurav Daniel Haldar

Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;

Saurav Daniel Haldar , Thatcher Ross Heumann , Maureen Berg , Anna Ferguson , Su Jin Lim , Hao Wang , Julie Nauroth , Dan Laheru , Elizabeth M. Jaffee , Nilofer Saba Azad , Neeha Zaidi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04117087

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS814)

DOI

10.1200/JCO.2023.41.4_suppl.TPS814

Abstract #

TPS814

Poster Bd #

P4

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

First Author: Saurav Daniel Haldar

First Author: Zev A. Wainberg

First Author: Tariq Arshad

First Author: Samuel Rosner